AMI Organics has signed a definitive multi-year, multi-tonne agreement with Fermion for the supply of an intermediate for their patented product.
Live Tv
Loading...
Shares of active pharmaceutical ingredient (API) and specialty chemicals maker AMI Organics rose on Monday after the company announced a multi-million euro deal with Fermion, an arm of Finland’s Orion Group.
The company has signed a definitive multi-year, multi-tonne agreement with Fermion for the supply of an intermediate for their patented product.
Fermion is a fully-owned subsidiary of Finland-based Orion Corporation. The total minimum contract value spread over a 10-year horizon is expected to be worth multi-million euros.